Stay updated on Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial
Sign up to get notified when there's something new on the Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial page.

Latest updates to the Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision marker updated to v3.6.4 on the page footer, indicating a new deployment. The study content and data remain unchanged.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page footer shows Revision: v3.6.3, replacing v3.6.2, indicating a small maintenance update to the site.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, indicating a platform/template update that affects the page wrapper rather than study information.SummaryDifference0.1%

- Check53 days agoChange DetectedThe study page now indicates that it is no longer recruiting participants, signaling that enrollment is closed. New navigation and guidance sections such as How to Read a Study Record, Common Questions, How to Join a Study, and an Intervention/Treatment heading were added, reflecting a reorganization and improved user guidance.SummaryDifference0.5%

- Check61 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, reflecting a small update to the page's content.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating a maintenance update to the document or site component. This reflects an internal change rather than an alteration to user-facing content.SummaryDifference0.1%

Stay in the know with updates to Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial page.